Lipoprotein Lipase (LPL) Test
🧬 Lipoprotein Lipase (LPL) Test — Complete Clinical Guide
Essential enzyme test for evaluating triglyceride metabolism disorders
Lipoprotein Lipase (LPL) is a key enzyme responsible for breaking down triglycerides (TG) in circulating lipoproteins. It plays a central role in lipid metabolism, and abnormalities in LPL concentration or activity can lead to severe hypertriglyceridemia, recurrent pancreatitis, and various hereditary lipid disorders.
Because of its strong connection with metabolic syndrome, familial chylomicronemia, and treatment monitoring, the LPL test has meaningful clinical value.
🧬 1. What Is Lipoprotein Lipase (LPL)?
LPL is an enzyme located on the surface of vascular endothelial cells, primarily in adipose tissue and skeletal muscle.
It hydrolyzes TG in chylomicrons and very-low-density lipoproteins (VLDL) to release free fatty acids (FFA).
LPL Function Overview
- Chylomicron → Free fatty acids + chylomicron remnants
- VLDL → Free fatty acids + IDL
- Provides energy substrate to adipose tissue & muscle
- Regulates postprandial lipemia
- Maintains normal triglyceride homeostasis
Failure of LPL function leads to massively elevated TG, sometimes producing a milky (lipemic) appearance in plasma.
🎯 2. Purpose of the LPL Test
1) Diagnose hereditary hypertriglyceridemia
- Type I hyperlipoproteinemia (LPL deficiency)
- APOC2 deficiency, LMF1 defects
- Familial chylomicronemia syndrome (FCS)
2) Evaluate causes of severe hypertriglyceridemia
- TG > 1,000 mg/dL
- Recurrent or acute pancreatitis
3) Monitor response to lipid-lowering therapy
- Fibrates (PPARα activators)
- Omega-3 fatty acids
4) Investigate secondary hypertriglyceridemia
- Uncontrolled diabetes
- Obesity, fatty liver disease
- Hypothyroidism
- Nephrotic syndrome
5) Research use
- Metabolic syndrome studies
- Lipid kinetics analysis
🧪 3. Specimen and Test Method
1) Specimen
- Heparinized plasma (green-top tube)
- 12-hour fasting recommended
- Post-heparin plasma may be required when measuring enzyme activity
- Heparin IV injection → blood draw 10 min later
2) Test Method — ELISA
In clinical laboratories, LPL is commonly measured using ELISA (Enzyme-Linked Immunosorbent Assay).
ELISA Principle
- Capture LPL antigen from plasma
- Add secondary anti-LPL antibody
- Enzyme–substrate color reaction
- Quantitative detection of LPL concentration
📌 Important: ELISA measures protein quantity, not functional activity.
Functional LPL deficiency may exist despite normal protein levels.
📏 4. Reference Range
Ranges vary by kit, analyzer, and lab.
Typical ELISA-based reference example:
164–284 ng/mL
Always follow the local laboratory’s validated reference interval.
🩺 5. Clinical Significance
A) LPL Increase
| Cause | Clinical Meaning |
|---|---|
| Exercise | Increased muscle LPL activity |
| Fibrate therapy | PPARα activation → ↑ LPL |
| Omega-3 therapy | Improved TG metabolism |
| Hyperthyroidism | Accelerated lipid turnover |
➡ Increase is usually physiological or treatment-related, not pathological.
B) LPL Decrease
| Cause | Clinical Implication |
|---|---|
| Genetic LPL deficiency (Type I Hyperlipoproteinemia) | TG > 2,000 mg/dL; pancreatitis risk extremely high |
| APOC2 deficiency | Cofactor loss → impaired LPL function |
| LMF1 defects | LPL maturation defect |
| Uncontrolled diabetes | ↓ insulin → ↓ LPL activity |
| Obesity, fatty liver | Impaired TG metabolism |
| Nephrotic syndrome | Cofactor proteins lost in urine |
| Hypothyroidism | Reduced lipid metabolism |
🧩 6. Interpretation Pearls
1) LPL concentration ≠ LPL activity
- Protein amount may be normal
- But enzymatic function markedly reduced
- Seen in APOC2 deficiency and some genetic variants
➡ If inconsistent with TG levels → consider functional assays or genetic testing.
2) Always interpret with triglyceride levels
- Severe TG elevation → likely LPL functional defect
- Normal TG + low LPL → suspect congenital deficiency
3) Importance of post-heparin samples
Heparin releases LPL from endothelium → needed for accurate activity measurement.
4) Check for medication effects
- Fibrates & omega-3 → LPL ↑
- Corticosteroids → TG ↑ → indirectly reduce LPL function
⚠️ 7. Precautions When Interpreting LPL Results
- 12-hour fasting required (postprandial TG interferes)
- Severe hypertriglyceridemia → lipemic specimens → assay interference
- ELISA = protein quantity, not activity
- Acute pancreatitis may show “pseudo-low LPL” due to severe TG overload
- Sepsis & systemic inflammation reduce physiological LPL levels
✅ 8. Summary
Lipoprotein Lipase (LPL) testing is essential for evaluating:
- severe hypertriglyceridemia,
- recurrent pancreatitis,
- hereditary lipid disorders,
- and treatment response.
ELISA-based LPL measurement is reliable when interpreted together with TG levels, clinical context, and—if needed—genetic testing.
📚 References
- Goldberg IJ. Lipoprotein lipase and lipid metabolism. J Lipid Res.
- Brahm AJ, Hegele RA. Chylomicronaemia—current diagnosis and future therapies. Nat Rev Endocrinol.
- Santamarina-Fojo S et al. Molecular basis of LPL deficiency. Trends Cardiovasc Med.
- Randox & Abcam LPL ELISA Kit Manuals.
- Feingold KR. Disorders of Lipoprotein Metabolism. Endotext.
- American Heart Association. Hypertriglyceridemia Management Guidelines.